Belching is a common bodily function, but when it escalates to a level that interferes with daily life, it is defined as belching disorders. International surveys have reported that approximately 1% of adults have belching disorders, but the percentage in Japan and the factors involved often elude medical professionals.

To examine the relationship between the rate of belching disorders, comorbidities, and lifestyles in Japan, a research team led by Professor Yasuhiro Fujiwara of Osaka Metropolitan University’s Graduate School of Medicine conducted a web survey of 10,000 adults. The results showed that 1.5%, or 151 people, had belching disorders. This was more prevalent in those who were men, drank alcohol, and were taking acid reflux medications.

Additionally, it was found that the presence of gastrointestinal disease, eating until feeling full, and extremely low or high chewing frequency were significantly associated with the development of belching disorders. Conversely, a high consumption of carbonated beverages had no association.

“The problem with belching disorders is that they take a long time to treat and are only practiced in a limited number of medical facilities,” stated Professor Fujiwara. “In the future, the evaluation of the number of times someone chews and the effects of improved dietary habits in patients with belching disorders will provide a treatment option for patients to perform on their own.”



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Before you post, please prove you are sentient.

What is melted ice?

Explore More

Fecal microbiota transplant recommended for the majority of recurrent C. diff patients

In the first comprehensive evidence-based guideline on the use of fecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends fecal microbiota transplant (FMT) for most patients with recurrent

Foundational technology to make cancer cells revert to normal cells?

Despite the development of numerous cancer treatment technologies, the common goal of current cancer therapies is to eliminate cancer cells. This approach, however, faces fundamental limitations, including cancer cells developing

E. coli bacteria exploits Crohn’s disease inflammation

A multi-year study of the role of E. coligut bacteria in Crohn’s disease finds that intestinal inflammation liberates chemicals that nourish the bacteria’s growth and promotes their ability to cause